AGR2-mediated lung adenocarcinoma metastasis novel mechanism network through repression with interferon coupling cytoskeleton to steroid metabolism-dependent humoral immune response

Cellular Immunology

Volumn 290, Issue 1, 2014, Pages 102-106

  Huang, Juxiang ^a,b   Wang, Lin ^a,b   Jiang, Minghu ^c   Chen, Qingchun ^a   Jiang, Zhenfu ^d   Feng, Haitao ^e  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c TSINGHUA UNIVERSITY   (China)

^d CHINA UNIVERSITY OF MINING AND TECHNOLOGY   (China)

^e HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Anterior gradient homolog 2 (AGR2); Humoral immune response; Lung adenocarcinoma; Mechanism

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN; INTERFERON;

7 ANTERIOR GRADIENT HOMOLOG 2 GENE; AEROBIC METABOLISM; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOSKELETON; DEFENSE MECHANISM; GENE EXPRESSION; HUMAN; HUMORAL IMMUNITY; LUNG ADENOCARCINOMA; METASTASIS; ONCOGENE; OVERLAPPING GENE; OXIDATIVE COUPLING; PRIORITY JOURNAL; STEROID METABOLISM;

ANTERIOR GRADIENT HOMOLOG 2 (AGR2); HUMORAL IMMUNE RESPONSE; LUNG ADENOCARCINOMA; MECHANISM;

ADENOCARCINOMA; CYTOSKELETON; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY, HUMORAL; INTERFERON-ALPHA; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIAL PROTEINS; NEOPLASM METASTASIS; PROTEINS; STEROL O-ACYLTRANSFERASE; TRANS-ACTIVATORS;

EID: 84904653040     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.05.008     Document Type: Article

References (33)

1. Chung K., Nishiyama N., Wanibuchi H., Yamano S., Hanada S., Wei M., Suehiro S., Kakehashi A. AGR2 as a potential biomarker of human lung adenocarcinoma. Osaka City Med. J. 2012, 58:13-24.
2. Aberger F., Weidinger G., Grunz H., Richter K. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech. Dev. 1998, 72:115-130.
3. Pohler E., Craig A.L., Cotton J., Lawrie L., Dillon J.F., Ross P., Kernohan N., Hupp T.R. The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol. Cell. Proteomics 2004, 3:534-547.
4. Maresh E.L., Mah V., Alavi M., Horvath S., Bagryanova L., Liebeskind E.S., Knutzen L.A., Zhou Y., Chia D., Liu A.Y., Goodglick L. Differential expression of anterior gradient gene AGR2 in prostate cancer. BMC Cancer 2010, 10:680.
5. Gupta A., Wodziak D., Tun M., Bouley D.M., Lowe A.W. Loss of anterior gradient 2 (Agr2) expression results in hyperplasia and defective lineage maturation in the murine stomach. J. Biol. Chem. 2013, 288:4321-4333.
6. Hu Z., Gu Y., Han B., Zhang J., Li Z., Tian K., Young C.Y., Yuan H. Knockdown of AGR2 induces cellular senescence in prostate cancer cells. Carcinogenesis 2012, 33:1178-1186.
7. Vanderlaag K.E., Hudak S., Bald L., Fayadat-Dilman L., Sathe M., Grein J., Janatpour M.J. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Breast Cancer Res. 2010, 12:R32.
8. Murray E., McKenna E.O., Burch L.R., Dillon J., Langridge-Smith P., Kolch W., Pitt A., Hupp T.R. Microarray-formatted clinical biomarker assay development using peptide aptamers to anterior gradient-2. Biochemistry 2007, 46:13742-13751.
9. Storey J.D. A direct approach to false discovery rates. J. Roy. Stat. Soc., Ser. B 2002, 64:479-498.
10. Wang Y., Joshi T., Zhang X.S., Xu D., Chen L. Inferring gene regulatory networks from multiple microarray datasets. Bioinformatics (Oxford, England) 2006, 22:2413-2420.
11. Wang L., Huang J., Jiang M., Lin H., Qi L., Diao H. Activated PTHLH coupling feedback phosphoinositide to G-protein receptor signal-induced cell adhesion network in human hepatocellular carcinoma by systems-theoretic analysis. ScientificWorldJournal 2012, 2012:428979.
12. Wang L., Huang J., Jiang M., Lin H., Qi L., Diao H. Inhibited PTHLH downstream leukocyte adhesion-mediated protein amino acid N-linked glycosylation coupling Notch and JAK-STAT cascade to iron-sulfur cluster assembly-induced aging network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by systems-theoretical analysis. Integr. Biol. (Camb.) 2012, 4:1256-1262.
13. Wang L., Huang J., Jiang M., Lin H. Tissue-specific transplantation antigen P35B (TSTA3) immune response-mediated metabolism coupling cell cycle to postreplication repair network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by biocomputation. Immunol. Res. 2012, 52:258-268.
14. Wang L., Huang J., Jiang M., Lin H. Signal transducer and activator of transcription 2 (STAT2) metabolism coupling postmitotic outgrowth to visual and sound perception network in human left cerebrum by biocomputation. J. Mol. Neurosci. 2012, 47:649-658.
15. Lin H., Wang L., Jiang M., Huang J., Qi L. P-glycoprotein (ABCB1) inhibited network of mitochondrion transport along microtubule and BMP signal-induced cell shape in chimpanzee left cerebrum by systems-theoretical analysis. Cell Biochem. Funct. 2012, 30:582-587.
16. Huang J., Wang L., Jiang M., Lin H., Qi L., Diao H. PTHLH coupling upstream negative regulation of fatty acid biosynthesis and Wnt receptor signal to downstream peptidase activity-induced apoptosis network in human hepatocellular carcinoma by systems-theoretical analysis. J. Recept. Signal Transduct. Res. 2012, 32:250-256.
17. Wang L., Sun L., Huang J., Jiang M. Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation. Cell Prolif. 2011, 44:291-299.
18. Wang L., Huang J., Jiang M., Zheng X. AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues. Tumour Biol. 2011, 31:417-425.
19. Wang L., Huang J., Jiang M., Sun L. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation. J. Cell. Biochem. 2011, 112:1286-1294.
20. Wang L., Huang J., Jiang M., Sun L. MYBPC1 computational phosphoprotein network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Cell. Mol. Neurobiol. 2011, 31:233-241.
21. Wang L., Huang J., Jiang M. CREB5 computational regulation network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Cell Biochem. Biophys. 2011, 60:199-207.
22. Wang L., Huang J., Jiang M. RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/cirrhotic liver tissues and human hepatocellular carcinoma (HCC). Cell. Physiol. Biochem. 2011, 26:303-310.
23. Sun L., Wang L., Jiang M., Huang J., Lin H. Glycogen debranching enzyme 6 (AGL), enolase 1 (ENOSF1), ectonucleotide pyrophosphatase 2 (ENPP2_1), glutathione S-transferase 3 (GSTM3_3) and mannosidase (MAN2B2) metabolism computational network analysis between chimpanzee and human left cerebrum. Cell Biochem. Biophys. 2011, 61:493-505.
24. Huang J.X., Wang L., Jiang M.H. TNFRSF11B computational development network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. J. Inflamm. (Lond.) 2011, 7:50.
25. Sun Y., Wang L., Jiang M., Huang J., Liu Z., Wolfl S. Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation. Cell Biochem. Biophys. 2010, 56:59-71.
26. Huang J., Wang L., Jiang M., Zheng X. Interferon α-inducible protein 27 computational network construction and comparison between the frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Open Genomics J. 2010, 3:1-8.
27. Wang L., Sun Y., Jiang M., Zheng X. Integrative decomposition procedure and Kappa statistics for the distinguished single molecular network construction and analysis. J. Biomed. Biotechnol. 2009, 2009:726728.
28. Wang L., Sun Y., Jiang M., Zhang S., Wolfl S. FOS proliferating network construction in early colorectal cancer (CRC) based on integrative significant function cluster and inferring analysis. Cancer Invest. 2009, 27:816-824.
29. Zhu J.M., Yu P.W. Downregulation of Tcell lymphoma invasion and metastasisinducing factor 1 induces cytoskeletal rearrangement and inhibits the invasive capacity of gastric cancer cells. Mol. Med. Rep. 2013, 8:425-433.
30. Lu J., Tan M., Cai Q. The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2014.
31. McKallip R.J., Nagarkatti M., Nagarkatti P.S. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J. Immunol. 2005, 174:3281-3289.
32. De Palma M., Mazzieri R., Politi L.S., Pucci F., Zonari E., Sitia G., Mazzoleni S., Moi D., Venneri M.A., Indraccolo S., Falini A., Guidotti L.G., Galli R., Naldini L. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell 2008, 14:299-311.
33. Wang L., Wu W.Z., Sun H.C., Wu X.F., Qin L.X., Liu Y.K., Liu K.D., Tang Z.Y. Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice. J. Gastrointest. Surg. 2003, 7:587-594.